Top compounds associated with response to LRRC36


Feature Type Standardized
Nominal ANOVA
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.045 0.2
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA spautin-1 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA Vandetanib FIMM pan-cancer AAC -0.24 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA AT-406 CTRPv2 pan-cancer AAC 0.067 0.2
mRNA betulinic acid CTRPv2 pan-cancer AAC -0.052 0.2
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.04 0.2
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
Download CSV